The crucial role of sleep in heart healing

Researchers examine how sleep impacts inflammation and recovery following a heart attack.

Cybin Brings in Capital with Public Offering | Psychedelic Invest

On Monday, publicly-traded psychedelic company Cybin announced an overnight public offering, and its stock paid the price. This came as no surprise to anyone following

August 2, 2023

FDA issues guidance on stimulant use disorder drug development

The FDA draft guidance comprises considerations on subject safety and requirements for filing new drug applications. Credit: JHVEPhoto/Shutterstock.com. The US Food and Drug Administration (FDA)

October 5, 2023

FDA OKs Another Injectable for Rare Kidney Disorder

Nedosiran (Rivfloza), a once-monthly RNA interference (RNAi) injection, gained FDA approval for certain patients with primary hyperoxaluria type 1 (PH1), drugmaker Novo Nordisk announced Monday.

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.